FDA approves new treatment for hospital-acquired and ventilator-associated bacterial pneumoniaFebruary 21, 2020
Statement by FDA Commissioner Scott Gottlieb, M.D., on the agency’s ongoing work to forcefully address the opioid crisisFebruary 21, 2020
Companies cease sales of e-liquids with labeling or advertising that resembled kid-friendly foods following FDA, FTC warningsFebruary 21, 2020
FDA approves new treatment to prevent bleeding in certain patients with hemophilia AFebruary 21, 2020
Statement from FDA Commissioner Scott Gottlieb, M.D. on new steps to improve FDA review of shared Risk Evaluation and Mitigation Strategies to improve generic drug accessFebruary 21, 2020
Statement from FDA Commissioner Scott Gottlieb, M.D. on FDA’s comprehensive new policy approach to facilitating the development of innovative regenerative medicine products to improve human healthFebruary 21, 2020
FDA unveils a streamlined path for the authorization of tumor profiling tests alongside its latest product actionFebruary 21, 2020
FDA approves pill with sensor that digitally tracks if patients have ingested their medicationFebruary 21, 2020
Statement from FDA Commissioner Scott Gottlieb, M.D., on developments in the romaine outbreak investigation, recent outbreaks and the use of modern tools to advance food safetyFebruary 21, 2020
Statement from FDA Commissioner Scott Gottlieb, M.D., on 2017 National Youth Tobacco Survey results and ongoing FDA efforts to protect youth from the dangers of nicotine and tobacco productsFebruary 21, 2020
Statement from FDA Commissioner Scott Gottlieb, M.D., on launch of ‘The Real Cost’ Youth E-Cigarette Prevention Campaign amid evidence of sharply rising use among kidsFebruary 21, 2020
Statement by FDA Commissioner Scott Gottlieb, M.D., on the FDA’s new resource guide to support responsible opioid prescribing for pain management in animalsFebruary 21, 2020
FDA warns API manufacturer involved in valsartan recall, provides information for patients taking these medicationsFebruary 21, 2020
FDA Announces Collaborative Review of Scientific Evidence to Support Associations Between Genetic Information and Specific MedicationsFebruary 20, 2020
FDA Works to Ensure Smooth Regulatory Transition of Insulin and Other Biological ProductsFebruary 20, 2020
Saratoga Potato Chips, LLC Issues Allergy Alert on Undeclared Milk in Kroger Sweet & Mesquite BBQ Potato ChipsFebruary 20, 2020
Colorado unapproved drug and dietary supplement makers ordered to cease operations for federal violationsFebruary 18, 2020
FDA Takes Action with Indian Government to Protect Consumers From Illicit Medical ProductsFebruary 18, 2020
